Back
HFA Premium Access

Enabling and optimizing RAASi therapy in cardio-renal patients by controlling potassium levels.

Session: Enabling and optimizing Renin-Angiotensin-Aldosterone-System inhibitors (RAASi) therapy in cardio-renal patients by controlling potassium levels
Topic: Miscellaneous
Speaker: Professor M. Boehm (Homburg, DE) Professor C. Lam (Singapore, SG)
Sponsored by Vifor Pharma/Vifor Fresenius Medical Care Renal Pharma
Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Congress Presentation

Add to my library

Like

About the speakers

Professor Michael Boehm

Saarland University Hospital, Homburg (Germany)
93 presentations
8 followers

Professor Carolyn S P Lam

Duke-NUS Graduate Medical School Singapore, Singapore (Singapore)
166 presentations
57 followers

1 more presentation in this session

Enabling and optimizing RAASi therapy in cardio-renal patients by controlling potassium level.

Speaker: Professor B. Pitt (Ann Arbor, US)

Access
Like
Thumbnail

Access the full session

Enabling and optimizing Renin-Angiotensin-Aldosterone-System inhibitors (RAASi) therapy in cardio-renal patients by controlling potassium levels

Speakers: Professor M. Boehm, Professor C. Lam, Professor B. Pitt
Access
Like
Thumbnail

About the event

Image

Heart Failure 2017 - 4th World Congress on Acute Heart Failure

29 April - 2 May 2017

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources